Menu

Report Library

All Reports

2011 Pre-ASCO Report

May 19, 2011

Abstracts from the 2011 annual American Society of Clinical Oncology (ASCO) meeting were released May 18 at 6pm EDT. The 2011 annual ASCO meeting will be held in Chicago, Illinois from June 3 through June 7.

We have bulleted some key findings from the abstracts, stocks to watch leading up to the meeting and stocks to watch during the meeting. Also included are numerous abstracts of particular interest for your perusal and an updated ASCO planner with links to all the abstracts via the abstract number. While this is just a brief overview, we will be available to discuss any data of interest in further detail. Please email clientservices@pharmaintel.informa.com or call your sales representative.

For the full report, please download the PDF version at the top of this page.

For our disclosures, please read the BioMedTracker Research Standards.

Indications Covered: Acute Lymphoblastic Leukemia (ALL)
Acute Myelogenous Leukemia (AML)
Anaplastic Large Cell Lymphoma (ALCL)
Brain Cancer (Malignant Glioma; AA and glioblastoma)
Brain Cancer (Secondary; Metastases)
Breast Cancer
Cancer
Chronic Lymphocytic Leukemia (CLL)/Small Cell Lymphocytic Lymphoma (SLL)
Chronic Myelogenous Leukemia (CML)
Colorectal Cancer (CRC)
Gastric Cancer
Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases)
Melanoma
Multiple Myeloma (MM)
Myelofibrosis (MF)
Neuroendocrine Tumors (NET)
Non-Small Cell Lung Cancer (NSCLC)
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cell Cancer (RCC)
Sarcoma - Unspecified
Small Cell Lung Cancer (SCLC)
Solid Tumors